Lactate dehydrogenase (L-Iactate:NAD oxidoreductase, EC 1.1.1.27) isoenzyme-3 (LD-3) has been isolated in milligram quantities from human erythrocytes.
Here we describe a revisedproduction method that yields milligram quantities of highly purified human LD-3. We alsopresent controlled proceduresfor labeling LD-3 with FITC and biotin, respectively, without inactivating the antigenic determinant specific for IgA.
MaterIals and Methods

Materials.
Human erythrocytes were obtained from packed cells stored in 250-mL bags (Biotrans, Dreieich, F.R.G.) and supplied by the blood bank of the hospital.
Human IgA(LD-3)2 complex was isolated from serum (1).
Unless otherwise noted, reagents were supplied by Merck (Darmstadt, F.R.G.). The biochemicals, of the highest purity available, were obtained from the following sources:
2-(4-hydroxyphenylazo)-benzoic acid (Aldrich Chemical Co., Brussels, Belgium); avidin, NAD, NAI)H, and pronase (Boehringer Mannheim, Mannheim, F.R.G.); dimethyl sulfoxide (OPG, Utrecht, The Netherlands); bovine serum albumin (BSA; Organon Teknika, Boxtel, The Netherlands);
5'-AMP-Sepharose
4B, diethylaminoethyl (DEAE)-Sephacel
and Sephadex G25 (Pharmacia, Uppsala, Sweden); NHS-LC-biotin (Pierce, Oud-Beijerland, The Netherlands);
human serum albumin (HSA; Red Cross Blood TransfusionService, Amsterdam, The Netherlands); dithiothreitol and fluorescein isothiocyanate (Serva, Heidelberg, F.R.G.); avidin-agarose and alkaline phosphatase-conjugated avidin (Sigma Chemical Co., St. Louis, MO); and goat antihuman (GAHu) IgA, specific for a-chain (Tago, Burlingame, CA).
Miscellaneous methods.
Total LD activity and protein concentrations were measured and the methods for agaragarose gel electrophoresis and polyacrylamide disc gel electrophoresis were performed as previously described (1). The sample load was 100 pg of protein per polyacrylarnide disc gel.
We used a temperature-conversion factor of 0.645 to compare LD activity assayed at 37#{176}C with that assayed at 30#{176}C (5) . To exchange buffers in small protein samples we performed the centrifuge column technique as described by Penefsky (6), using Sephadex G25 as the stationary phase. After setting the concentrations of Tris, EDTA, and dithiothreitol at 20, 1, and 2 mmolJL, respectively, and adjusting the pH to 7.40, we stirred the solution for 30 mm and then centrifuged it (38 000 x g, 15 mm, 4#{176}C). The clear supernatant fluid (5600 mL) was passed through a 5 x 20cm DEAE-Sephacel column that had been pre-equilibrated with buffer A (20 mmol/L Tris HC1, pH 7.40, containing, per liter, 1 mmol of EDTA and 2 mmol of dithiothreitol).
After thoroughly washing the column with the same buffer (about 1.5 L), we eluted the adsorbed LD-3 with buffer A containing 50 mmol of NaC1 per liter. Enzymatically active fractions were pooled and used without further treatment for the next step.
Finally, we purified the LD-3 from these pooled fractions according to the method of Pettit Fluorescein labeling of LD-3. The coupling reaction was carried out, with shaking, in darkness at pH 9.20 and with about a 45-fold molar excess of FITC over LD-3. To prepare the fluorochrome solution, we dissolved 8 mg of F1TC in 20 mL of dimethyl sulfoxide plus 30 mL of a freshly prepared 20 g/L sodium hydrogen carbonate solution.
To determine the extent of labeling of LD-3 by FITC, we first diluted, without delay, a small aliquot of the fluorochrome solution 41-fold in buffer B (50 mmol/L sodium carbonate, pH 9.2) and stored this in darkness at ambient temperature.
We typically reacted 1.65mg of purified LD-3 (dissolved in 6 mL of buffer B containing, per liter, 100 mmol of NaCl and 1 mL of glycerol) with 1.28 mL of the fluorochrome solution at ambient temperature for 5 h. The reaction was terminated by exchanging the solvent against buffer C (100 mmol/L Na2HPO4/KH2PO4, pH 7.00, containing 100 mmol of NaCl, 200 mg of NaN3, and 1 mL of glycerol per liter). To stabilize the FITC-labeled LD-3, we added HSA to give a final concentration of 9.1 g of HSA per liter. The preparation was sterilized by filtration as doscribed above.
To monitor the rate of decrease of LD-3 activity in the reaction system, we removed 20-FL aliquots of the reaction mixture, diluted them 101-fold with buffer C containing 1 g of HSA per liter (lacking NaCl), and assayed for LD
activity.
Imaging technique. To examine the fluorescence intensity of the FITC-conjugated LD-3, we added 0.2 mL of the conjugate-containing solution to an equal volume of a suspension of 5'-AMP-Sepharose 4B spheres (0.1 g/1.5 mL) in buffer C (lacking NaCI). After incubation for 45 mm at room temperature, we thoroughly washed the spheres with the same buffer and centrifuged them three times at 150 x g for 5 min. Finally, we discarded the supernate, resuspended the pellet in 0.2 mL of the same buffer, and then mixed this suspension with an equal volume of a suspension of unincubated spheres. Serial dilutions of the final suspension were mounted on glass slides and examined with a Leitz fluorescence microscope (Wetzlar, F.R.G.; ex 490 nm; hem530 nm).
Interaction experiments.
To quantilr the association between complex IgA, and F1TC-labeled LD-3, we performed interaction experiments by a method described elsewhere (3).
Biotinylation of LD-3. We conjugated biotin to LD-3 by using NHS-LC-biotin. We dissolved 3.0mg of purified LD-3 in 3 mL of buffer D (100 mmol/L sodium carbonate, pH 8.60, containing 100 mmol of NaCl per liter) and added NHS-LC-biotin dissolved in buffer D (lacking NaCl) to give about a 50-fold molar excess with respect to LD-3. The reaction was allowed to proceed for 5 h. To follow the rate of decrease of LD-3 activity in the reaction system and to terminate the reaction, we used the same methods as described above. To stabilize the biotmnylated LD-3, we added HSA to give a final concentration of 9.1 g of HSA per liter. The final preparation was sterilized by filtration as described above.
Determination
of biotin groups per LD-3 molecule. The average number of biotin groups attached to each LD-3 molecule was determined spectrophotometrically according to Green (12) .
Coupling confirmation study. To illustrate the introduction of biotin into LD-3, we added 1.0 mL of a diluted 
Results
Enzyme purification.
When activated carbon was used during the preparation of the hemolysate, any fragments of adipose material were removed effectively and no problems were encountered in loading the DEAE-Sephacel column with 5600 mL of hemolysate. During this step the LD-3 activity was eluted in two completely separated peaks, cis-LD-3 and trans-LD-3. (SD 3.5 UIL). LD-3 was purified about 23000-fold to homogeneity with the specific activity of 435 U per milligram of protein, and the yield was 89%. Starting with five bags of packed cells, we recovered 8.2 mg of purified LD-3. Agaragarose gel electrophoresis of the purified and native LD-3 demonstrated LD activity only at the position of the LD-3 band, and the homogeneity of the preparation was established by the presence of a single proteinband on polyacrylamide disc gel electrophoresis at pH 8.9. After sterilization by passage through a 0.2-.tm (pore size) ifiter, the purified preparation of LD-3 was fairly stable when stored at 4#{176}C; i.e., no loss of enzyme activity was observed in two months.
Amino acid composition. Table 1 gives the results of the amino acid composition of LD-3. The values are given in residues per molecule of protein, assuming a relative molecular mass of 140000. The low recovery of half-cystine has been observed with many other LDs (14) (15) (16) .
FITC-labeled LD-3. Fluorescein thiocarbamylation of purified LD-3 with about a 45-fold molar excess of FFFC over protein at pH 9.2 at ambient temperature resulted in little loss of enzyme activity; enzyme activity was 14% less after 5 h. It is further apparent from the data presented in Figure IA In the agar-agarose LD isoenzyme electrophoretic pattern the 2-h conjugated preparation moved as a single band slightly anodal to the position of LD-3, whereas the LD activity of the 5-h conjugated preparation was only present between the positions of the LD-2 and LD-3 bands.
After sterilization of these FITC-conjugated LD-3 preparations, both conjugates were somewhat unstable and lost 7% of theiractivity per 100 days when stored at 4#{176}C.
To quantify the interaction ability between IgA,, and the FJ.TC-labeled LD-3, we coated polystyrene microtiter plates with purified IgA(LD-3)2 complex at 2.2 jzg/mL of coating buffer and dissociated the complex by treatment with glycine HC1. The purified LD-3 and with 2-and 5-h conjugated LD-3. The interaction indices (3) shown in Table 3 indicate that the reassociation of the labeled LD-3 and IgA gave rise to 75% of the original complex activity. To determine whether sufficient fluorescence intensity will in fact be produced when IgA B lymphocytes are incubated with FITC-conjugated LD-3, we simulated this processby incubating 5'-AMP-Sepharose 4B beads with 5-h conjugated LD-3. In the agar-agarose LD-isoenzyme electrophoretic pattern, both the 70-and 240-mn preparation migrated at the same rate as the untreated LD-3.
After sterilization
of both preparations, these conjugates were extremely stable and, stored at 4#{176}C, remained fully active for at least two months.
We analyzed these biotin-conjugated LD-3 preparations, to determine the effect of the amount of biotin substitution in LD-3 in relation to the binding to avidin. We mixed the conjugate with a 200-fold excess of avidin-agarose and assayed the supernate for LD activity as a function of the time. Almost immediately after the addition of conjugate the curves for both conjugates (Figure 3) showed a halved LD activity. In addition, for both 70-and 240-mn conjugated LD-3 the fast decrease was followed by a slower further decrease of activity up to 13% and 5%, respectively, by the 60th mm.
To confirm the existence of an IgA-LD-3-biotin-avidin bridge, we coated antibodies to human IgA to polyvinyl microtiter plates and incubated with purified IgA(LD-3)2 complex, 240-mn biotin-conjugated LD-3, and alkaline phosphatase-conjugated avidin, respectively. In the course 
Discussion
Purification of human LD-3. We fundamentally improved the method of Pridgar et al. (7) for the isolation of LD-3 from human erythrocytes. As a result the final product had outstanding characteristics.
We were able to remove the impurities, leaving an enzyme preparation with a specific activity nearly 3. is the unprotonated a-amino group (17) . Because the amino terminus of the mature U) protein is blocked by acetylation (18), mainly the #{128}-amino groups of lysine participate in the reaction at higher pH, particularly above pH 9.0. Evidence for the presence of lysine residues in LD-3 was presented by the amino acid composition of this isoenzyme (Table 1) . We found a lower content of lysine residues as compared with the known content of lysine residues of LD from a number of vertebrates (14-16). This result, together with the observation that some e-amino groups are hidden in the three-dimensional structure of the molecule (19) and the instability of the LD-3 molecule, might contribute to the failure of the current procedures for labeling of proteins with FITC (20) in the case of LD-3. However, our results indicated that conjugation performed at pH 9.20 in the presence of about a 45-fold molar excess of FITC over protein at ambient temperature resulted in a FITC/LD-3 molar ratio of 3.3:1 within 5 h ( Table 2) .
The antigenic determinant of LD-3 with respect to IgA,,, can be disturbed severely due to conformational changes introduced by the conjugation of a functionally important s-amino group. Therefore, we investigated the effect of the level of conjugation of LD-3 on the functional activity to react with IgA. Our studies on reassociation confirmed that by the introduction of three F1TC molecules per LD-3 molecule the original complex activity was 75% restored (Table 3 ). These findings indicate that the antigenic determinant isnot altered by the thiocarbamylation reaction. The slightly lessened activity might be due to the conjugationof lysine residues located in the NH2-tail of a subunit, the function of which appears to stabilize the quaternary structure of the tetrameric LD molecule through the subunit contact with the COOH "arm" of another subunit (21).
The study of which Figure 2 is a part illustrates one application in which the label was localized exclusively on 5'-AMP-Sepharose 4B beads. Because 1 mL of 5'-AMPSepharose 4B gel contains about 10 spheres and the binding capacity for LD is about 10 mg of enzyme per milliliter of gel, the total amount of attached LD molecules is of the order of magnitude of 10/140 000' iO--6-10-106 = 0.43 x 1011 per sphere. The mean diameter of a sphere is 115 .un; therefore, one sphere will contain about 1 x 106 LD molecules per 1 m2. 
Biotinylation
